Journal article
Effectiveness and Safety of Rivaroxaban Versus Warfarin in Frail Patients with Venous Thromboembolism
Abstract
PURPOSE: Frailty predicts poorer outcomes in patients receiving anticoagulation. We assessed the effectiveness and safety of rivaroxaban vs warfarin in frail patients experiencing venous thromboembolism.
METHODS: Using US MarketScan claims data from January 2012-December 2016, we identified frail patients (using the Johns Hopkins Claims-Based Frailty Indicator score) who had ≥1 primary hospitalization/emergency department visit diagnosis codes …
Authors
Coleman CI; Turpie AGG; Bunz TJ; Beyer-Westendorf J
Journal
The American Journal of Medicine, Vol. 131, No. 8, pp. 933–938.e1
Publisher
Elsevier
Publication Date
August 2018
DOI
10.1016/j.amjmed.2018.02.015
ISSN
0002-9343